Omeprazole quadruple therapy for duodenal ulcer clinical observation of 52 cases.docVIP

Omeprazole quadruple therapy for duodenal ulcer clinical observation of 52 cases [Keywords:] omeprazole quadruple therapy for duodenal ulcer Helicobacter pylori infection in duodenal ulcer is caused by an important reason. HP HP eradication therapy in the treatment of peptic ulcer occupy an important position. The traditional method of treatment with the HP receptor antagonist, PPI treatment generally I was 4 ~ 8 w. hospital with omeprazole, clarithromycin, colloidal bismuth pectin, amoxicillin quadruple therapy for Helicobacter pylori positive duodenal ulcer clinical observation of 52 cases, a significant effect. 1 Data and methods 1.1 General information on 52 patients. Were confirmed to have outpatient endoscopy in patients with duodenal ulcer, gastric mucosa by endoscopic biopsy rapid urease test and biopsy confirmed detection of H. pylori infection, aged 18 to 60 age, duration of 1 to 20 years, including 21 males and 31 females. 1.2 Methods of omeprazole 20 mg, 2 times / d, clarithromycin 250 mg, 2 times / d, bismuth pectin 150 mg, 3 times / d, amoxicillin 500 mg, 3 times / d, 10 d treatment . adverse drug reactions during treatment records and abdominal pain situation. 1.3 The effect of the standard results based on gastroscopy and symptoms (ulcer pain and to determine the degree of improvement, Endoscopy efficacy criteria: healing: ulcer disappeared, scar formation, Effective: reduced ulcer than before, reducing inflammation, invalid: no change in ulcer . H. pylori testing standards: 4 w-line drug after the endoscopic mucosal biopsy, rapid urease test and histological examination line organizations, both negative, as H. pylori negative. Abdominal pain efficacy criteria: markedly: abdominal pain disappeared, Improvement: abdominal pain relieve than before, does not affect the work, invalid: no relief or worsening abdominal pain. 2 Results 2.1 omeprazole quadruple therapy for duodenal ulcer 52 cases, 48 #8203;#8203;cases re